Scott A Koepsell
Overview
Explore the profile of Scott A Koepsell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
938
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cox J, Koepsell S
Lab Med
. 2020 May;
51(4):e45-e46.
PMID: 32386057
The recent SARS-CoV-2 outbreak has placed immense pressure on supply chains, including shortages in nasopharyngeal (NP) swabs. Here, we report our experience of using 3D-printing to rapidly develop and deploy...
12.
Abdalhamid B, Bilder C, McCutchen E, Hinrichs S, Koepsell S, Iwen P
Am J Clin Pathol
. 2020 Apr;
153(6):715-718.
PMID: 32304208
Objectives: To establish the optimal parameters for group testing of pooled specimens for the detection of SARS-CoV-2. Methods: The most efficient pool size was determined to be five specimens using...
13.
Dean C, Hooper J, Dye J, Zak S, Koepsell S, Corash L, et al.
Transfusion
. 2020 Mar;
60(5):1024-1031.
PMID: 32129478
Background: In 2014, passive immunization by transfusion of Ebola convalescent plasma (ECP) was considered for treating patients with acute Ebola virus disease (EVD). Early Ebola virus (EBOV) seroconversion confers a...
14.
Gundabolu K, Goldsweig A, Bhatt V, Koepsell S, Harper J
Haemophilia
. 2019 Nov;
26(1):e5-e8.
PMID: 31694063
No abstract available.
15.
Cox J, Shunkwiler S, Koepsell S
Lab Med
. 2019 Jun;
48(4):367-371.
PMID: 31173633
Thromboembolism is a condition that leads to the hospitalization of thousands of patients in the United States annually. Recent guidelines suggest that testing for hereditary, acquired and combined forms of...
16.
Luebker S, Koepsell S
Front Oncol
. 2019 May;
9:268.
PMID: 31058079
BRAF inhibitor therapy may provide profound initial tumor regression in metastatic melanoma with BRAF V600 mutations, but treatment resistance often leads to disease progression. A multi-center analysis of BRAF inhibitor...
17.
Umakanthan J, Dhakal P, Gundabolu K, Koepsell S, Baljevic M
Maedica (Bucur)
. 2018 Jun;
13(1):71-73.
PMID: 29868144
Congenital factor VII deficiency is a challenging disorder to manage, as it is associated with varied genotypes that do not clinically correlate with a bleeding phenotype. Individuals with severe factor...
18.
Luebker S, Zhang W, Koepsell S
Oncotarget
. 2018 Feb;
8(70):114877-114893.
PMID: 29383127
Insulated culture environment and prolonged propagation contribute to known limitations of cell lines, and selection is often limited to availability or favorable growth characteristics. To better characterize and improve selection...
19.
Lintel N, Luebker S, Lele S, Koepsell S
Hum Pathol
. 2018 Jan;
73:122-127.
PMID: 29307622
Morphologically, distinguishing between leiomyoma (LM) and leiomyosarcoma (LMS) is not always straightforward, especially with benign variants such as bizarre leiomyoma (BLM). To identify potential markers of malignancy in uterine smooth...
20.
Lintel N, Brown D, Schafer D, Tsimba-Chitsva F, Koepsell S, Shunkwiler S
Immunohematology
. 2017 Apr;
33(1):22-26.
PMID: 28425752
Daratumumab is an antibody currently used in the treatment of patients with refractory multiple myeloma. Blood samples from patients being treated with daratumumab may show panreactivity during pre-transfusion testing. To...